23

Aug

2017

Envolve Pharmacy Solutions: Lorazepam Oral Concentrate, USP 2mg/mL by Amneal Pharmaceuticals: Recall - Misprinted Dosing Droppers

URGENT FDA Notice - Recall

Amneal Pharmaceuticals LLC is voluntarily recalling 13 lots of Lorazepam Oral Concentrate, USP 2mg/mL, to the Consumer level due to a defect in the dropper markings.
Read More...

18

Aug

2017

OptumRx: Recall of Lorazepam Oral Concentrate by Amneal

Effective: August 14th 2017

On August 14, 2017, Amneal announced a recall of some lots of Lorazepam 2 mg/mL oral concentrate because of a defect in the dropper markings.
Read More...